Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farshid Dayyani

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Clinical Advances in Hematology & Oncology : H&O|December 1, 2023
Novel combination approaches to locoregional and systemic therapy in the management of primary and metastatic liver tumorsMichelle Dai, Bryan-Clement Y Tiu, Millennie Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2022
Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular CarcinomaAndrew X Zhu, Farshid Dayyani, Chia-Jui Yen, et al.
Cancers|July 13, 2024
The Impact of Local Control on Overall Survival after Y-90 Selective Internal Radiotherapy of Liver Metastases in Oligometastatic Cancer: A Retrospective AnalysisJohn Yeakel, Steven N Seyedin, Garrett Harada, et al.
European Journal of Immunology|April 26, 2012
Transcript profiling of CD16-positive monocytes reveals a unique molecular fingerprintMarion Frankenberger, Thomas P J Hofer, Ayman Marei, et al.
Future Oncology (London, England)|May 23, 2022
A phase Ib feasibility trial of response adapted neoadjuvant therapy in gastric cancer (RANT-GC)Farshid Dayyani, Brian R Smith, Ninh T Nguyen, et al.
American Journal of Hematology|April 22, 2011
Prediction model for mortality after intracranial hemorrhage in patients with leukemiaFarshid Dayyani, Sarah Schellhorn Mougalian, Kiran Naqvi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 18, 2024
Hereditary Cancer Clinics Improve Adherence to NCCN Germline Testing Guidelines for Pancreatic CancerClaudia Rosso, Naomie Devico Marciano, Deepika Nathan, et al.
Plos One|January 10, 2013
Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathwaysFarshid Dayyani, Nila U Parikh, Andreas S Varkaris, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2020
Neoadjuvant Immunotherapy-Based Systemic Treatment in MMR-Deficient or MSI-High Rectal Cancer: Case SeriesRahel Demisse, Neha Damle, Edward Kim, et al.
The Oncologist|June 28, 2025
Phase 1 study of zavondemstat (TACH101), a first-in-class KDM4 inhibitor, in patients with advanced solid tumorsApostolia M Tsimberidou, Farshid Dayyani, David Sommerhalder, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Clinical Advances in Hematology & Oncology : H&O|December 1, 2023
Novel combination approaches to locoregional and systemic therapy in the management of primary and metastatic liver tumorsMichelle Dai, Bryan-Clement Y Tiu, Millennie Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2022
Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular CarcinomaAndrew X Zhu, Farshid Dayyani, Chia-Jui Yen, et al.
Cancers|July 13, 2024
The Impact of Local Control on Overall Survival after Y-90 Selective Internal Radiotherapy of Liver Metastases in Oligometastatic Cancer: A Retrospective AnalysisJohn Yeakel, Steven N Seyedin, Garrett Harada, et al.
European Journal of Immunology|April 26, 2012
Transcript profiling of CD16-positive monocytes reveals a unique molecular fingerprintMarion Frankenberger, Thomas P J Hofer, Ayman Marei, et al.
Future Oncology (London, England)|May 23, 2022
A phase Ib feasibility trial of response adapted neoadjuvant therapy in gastric cancer (RANT-GC)Farshid Dayyani, Brian R Smith, Ninh T Nguyen, et al.
American Journal of Hematology|April 22, 2011
Prediction model for mortality after intracranial hemorrhage in patients with leukemiaFarshid Dayyani, Sarah Schellhorn Mougalian, Kiran Naqvi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 18, 2024
Hereditary Cancer Clinics Improve Adherence to NCCN Germline Testing Guidelines for Pancreatic CancerClaudia Rosso, Naomie Devico Marciano, Deepika Nathan, et al.
Plos One|January 10, 2013
Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathwaysFarshid Dayyani, Nila U Parikh, Andreas S Varkaris, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2020
Neoadjuvant Immunotherapy-Based Systemic Treatment in MMR-Deficient or MSI-High Rectal Cancer: Case SeriesRahel Demisse, Neha Damle, Edward Kim, et al.
The Oncologist|June 28, 2025
Phase 1 study of zavondemstat (TACH101), a first-in-class KDM4 inhibitor, in patients with advanced solid tumorsApostolia M Tsimberidou, Farshid Dayyani, David Sommerhalder, et al.
Pageof 12